Sequential hemibody radiotherapy in poor prognosis localized adenocarcinoma of the prostate gland: a preliminary study of the RTOG

Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):215-8. doi: 10.1016/0360-3016(89)90033-3.

Abstract

Ten patients with poor prognosis localized adenocarcinoma of the prostate gland received local regional radiotherapy to the prostate gland followed by sequential radiation therapy to the lower hemibody and the upper hemibody. The treatment technique is presented and its feasibility demonstrated. Five patients are alive, free of disease, with a minimum of 20 months follow-up. The most common adverse effect was prolonged reversible bone marrow suppression.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / radiotherapy*
  • Aged
  • Humans
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Prognosis
  • Prostatic Neoplasms / radiotherapy*
  • Whole-Body Irradiation* / adverse effects